Informations sur le produit
DC260126 is an investigational drug for the treatment of human breast cancer. DC260126 is a G-protein coupled receptor agonist that increases energy metabolism and insulin secretion from β-cells in the pancreas. This drug has been shown to reduce atp levels in human serum and increase cytosolic Ca2+ concentrations in cancer cells. DC260126 also has anti-inflammatory properties, which may be due to its ability to inhibit prostaglandin synthesis. It has been shown to decrease hepatic steatosis, which can cause metabolic disorders such as diabetes mellitus type 2 and insulin resistance. DC260126 has potential as a drug target for diseases related to mitochondrial dysfunction, such as Alzheimer's disease and Parkinson's disease.
Propriétés chimiques
Question d’ordre technique sur : 3D-WNA69204 DC260126
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
